As NKP1 was a single-centre phase 1 trial with a limited number of participants, to protect individual patient confidentiality the source data which is provided is a limited dataset sufficient to reproduce the figures and conclusions presented in this manuscript
Because its considered off-label, theres little clinical evidence to show whether this kind of do-it-yourself dosing is actually effective, or just anecdotal
PlexusDx pairs its Weight Management Protocols Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral with the Precision Peptide Genetic Test, reading 14 pathways, 49 peptides, 150+ genetic insights across FTO, GLP1R, MC4R, and TCF7L2
These medications work in different ways, so there is no direct conflict between them